Cervilenz (Chagrin Falls, OH) a development-stage device company focused on the a disposable to identify and manage pregnant women at high risk for preterm birth, closed an $8.35M Series A financing. Participants include Arboretum Ventures and Chrysalis Ventures.

Tangent Medical Technologies (Ann Arbor, MI) a development-stage medical device company focused on peripheral intravenous delivery systems, closed a $4.5M Series A financing. Participants include Arboretum Ventures, Flagship Ventures and Osage Ventures.

AuraSense Therapeutics (Evanston, IL) a development-stage biotechnology company focused on nucleic acid constructs for heart disease, cancer, skin conditions and bacterial infection, closed a $4.5M Series B financing. Participants include Abbott Biotech Ventures.

Intervention Insights (Grand Rapids, MI) a commercial-stage personalized medicine company focused on molecularly targeted oncology therapies, closed a $7.2M Series B financing. Participants include Beringea, Chrysalis Ventures, Hopen Life Science Ventures and Michigan Accelerator Fund.
Thanx for your patience as we catch-up.

Cleveland Heartlab (Cleveland, OH) a commercial-stage specialty clinical laboratory and disease management company focused on assessing cardiovascular risk, closed a $18.4M Series B financing. Participants include Excel Venture Management and HealthCare Ventures.
Thanx for your patience as we catch-up.

NanoDetection Technology (Cincinnati, OH) a development-stage in vitro poc diagnostic platform focused on uses in healthcare, food safety and bioterrorism, closed a $2.3M Series A financing. Participants include CincyTech.
Thanx for your patience as we catch-up.

SironRx Therapeutics (Cleveland, OH) a clinical-stage regenerative therapy company focused on wound repair and scarring prevention, closed a $3.4M Series A financing. Participants include North Coast Angel Fund, Cleveland Clinic, JumpStart, Fletcher Spaght Investments, Glengary, Ohio Tech Angel Fund and Early Stage Partners.
Thanx for your patience as we catch-up.

Entellus Medical (Maple Grove, MN) a commercial-stage medical device company focused on minimally invasive treatments for chronic sinusitis, closed a $35M Series E financing. Participants include Covidien Ventures, SV Life Sciences, Essex Woodlands, Split Rock Partners and Greenspring Associates.
Thanx for your patience as we catch-up.

NanoDetection Technology (Franklin, OH) a development-stage point-of-care diagnostic platform, closed a $2.3M Series A financing. Participants include CincyTech.

Explorys (Cleveland, OH) a development-stage medical informatics company focused on a patient population, treatment protocols and clinical outcomes intelligence platform,closed a $11.5M Series C financing. Participants include Austin Ventures, Foundation Medical Partners, Santé Ventures and Cleveland Clinic.

Ability Network (Minneapolis, MN) a commercial-stage medical IT company focused on care coordination and collaboration, closed a $27M Series C financing. Participants include Bain Capital Ventures and Lemhi Ventures.

Molecular Imaging Research (Ann Arbor, MI) a commercial-stage specialty contract research organization providing small animal in vivo multi-modality imaging services, closed a $7M Series A financing. Participants include Baird Venture Partners and Arcus Ventures.

Naurex (Evanston, IL) a clinical-stage pharmaceutical company focused on depression and other CNS-related disorders, closed a $18M Series A financing. Participants include Adams Street Partners, Latterell Venture Partners, Druid BioVentures, Genesys Capital, PathoCapital, Lundbeck, Takeda Ventures and Shire.